sicklecellanemianews3 天
First patient enrolled in Phase 1 trial testing fostamatinib for SCD
The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle ...
Future Market Insights5 天
Europe’s Platelet Rich Plasma (PRP) Market to Surpass USD 80.3 Million by 2033 Amid ...
The European platelet rich plasma (PRP) market is poised for steady growth, with projections indicating a valuation exceeding ...